Skip to main content
    C

    Celularity Inc (CELU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.62
    -0.01 (-1.75%)

    Market Cap: $20.45M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Celularity Inc (CELU) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Celularity are Pluri (PLUR), CEL-SCI (CVM) and NextCure (NXTC). By market cap, Celularity ranks 8th of the 13 companies on this page; Telomir Pharmaceuticals, Inc. Common Stock (TELO) is the largest at $36.15M.

    Peer Comparison

    CELU's revenue growth of -5.3% is above the peer median of -27.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Celularity (CELU)$20.45MN/A1.0x-245.7%N/A-5.3%0.00%
    Pluri Inc. (PLUR)$15.09MN/A8.7x0.0%-650.8%-15.8%0.00%
    CEL-SCI Corp (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Collplant Biotechnologies Ltd (CLGN)$14.27MN/A21.0x0.0%N/A-39.7%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Briacell Therapeutics Corp (BCTX)$29.60MN/AN/A0.0%N/A0.0%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    Biocardia Inc (BCDA)$12.58MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$22.44MN/A16.4x0.0%-109.0%-27.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Celularity, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Pluri Inc. (PLUR)
    Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy...
    PLUR competitors
    CEL-SCI Corp (CVM)
    CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases.
    CVM competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Collplant Biotechnologies Ltd (CLGN)
    CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs...
    CLGN competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Briacell Therapeutics Corp (BCTX)
    BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
    BCTX competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    Biocardia Inc (BCDA)
    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease.
    BCDA competitors

    Frequently Asked Questions About CELU

    Who are Celularity's main competitors?

    The companies most similar to Celularity include Pluri (PLUR), CEL-SCI (CVM), NextCure (NXTC), Collplant Biotechnologies (CLGN) and Estrella Immunopharma (ESLA), listed from the closest match.

    Who is Celularity's biggest competitor?

    Telomir Pharmaceuticals, Inc. Common Stock (TELO) is the largest of the similar companies at $36.15M; Pluri (PLUR) is the closest match by business profile, size, sector and industry.

    How does CELU stock compare with its competitors?

    CELU's P/S is 1.0x against a peer median of 16.4x; its net margin is -245.7% against a peer median of 0.0%.

    Which of Celularity's competitors pays a higher dividend?

    Celularity pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Celularity bigger than its competitors?

    No. Celularity is 8th by market cap among the 13 companies on this page; the largest is Telomir Pharmaceuticals, Inc. Common Stock (TELO) at $36.15M.